Correction to: Can Delta Radiomics Improve the Prediction of Best Overall Response, Progression-Free Survival, and Overall Survival of Melanoma Patients Treated with Immune Checkpoint Inhibitors? (Cancers, (2024), 16, 15, (2669), 10.3390/cancers16152669)

There was an error in the original publication [1]. Section 2.4 in the manuscript and S2.2 in the supplementary should contain the information “and presence of new metastases in first follow-up CT” for the description of the clinical features used as input. A correction has been made to Section 2.4 in the manuscript and S2.2 in the supplementary. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.